About Arcellx (ACLX)
Arcellx Inc. is a clinical-stage biotechnology company. The Company is focused developing controllable cell therapies for the treatment of patients with cancer and other incurable diseases. The Company is advancing its CART-ddBCMA product through its... Read more
- USD85.83
- USD86.09
- USD82.63
- USD107.37
- 10.00%
- 57M
- 483.03k
- 542.72k
- 4.8B
- 47.86
- -5.20%
Stock News
2 hours ago
Trump’s China trip could bring good news for markets — but also prolong the government shutdown into November
MarketWatch
3 hours ago
Trump administration port fees slam shipper with $34 million tariff bill: "A lot of shaking of heads," says shocked U.S. freight CEO
CNBC
3 hours ago
Orrstown Financial Services Inc (ORRF) Q3 2025 Earnings Call Highlights: Record Earnings and ...
Yahoo
3 hours ago
The OpenAI halo gives GE Vernova a needed lift, plus what's behind Meta's moves
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
